Wells Fargo Upgrades Johnson & Johnson (JNJ) to Outperform; Pharma Pipeline Moves To Forefront As Consumer Risk Dissipates
Tweet Send to a Friend
Wells Fargo upgraded Johnson & Johnson (NYSE: JNJ) from Market Perform to Outperform. Valuation range increased from $67-68 to $70-72.
Wells ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wells ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
